Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial

Figure 4

Modified Rankin Scale score distribution at baseline onset, discharge, and day 30 of stroke in the experimental group (DLBS1033 therapy+standard treatment).